2024-11-07 - Analysis Report
## Teladoc Health Inc (TDOC) Stock Analysis

**1. Stock Performance Comparison:**

Teladoc Health Inc (TDOC) has underperformed the S&P 500 (VOO) significantly.  As of the latest data point, TDOC has a cumulative return of 53.56%, while VOO has a return of 138.41%. This represents a **-84.85%** divergence from VOO, which is in the 10th percentile of historical divergence. 

**Alpha & Beta Analysis:**

| Year | CAGR | MDD | Alpha | Beta |
|---|---|---|---|---|
| 2015 | -5.5% | 51.0% | -4.7% | 1.0 |
| 2016 | -8.3% | 16.3% | -19.7% | 1.5 |
| 2017 | 111.2% | 19.7% | 92.6% | 1.7 |
| 2018 | 36.9% | 46.7% | 43.9% | 1.8 |
| 2019 | 73.8% | 26.3% | 45.1% | 2.0 |
| 2020 | 140.2% | 29.5% | 125.0% | 0.2 |
| 2021 | -54.2% | 55.8% | -83.0% | 1.4 |
| 2022 | -75.1% | 13.6% | -55.1% | 2.0 |
| 2023 | -4.6% | 18.2% | -29.4% | 2.3 |
| 2024 | -59.5% | 35.2% | -80.2% | 1.4 |

The analysis indicates that TDOC has experienced significant volatility, with high beta values suggesting it is more sensitive to market fluctuations than the S&P 500. While TDOC has shown periods of strong alpha (outperformance relative to the market), it has also faced significant underperformance, especially in recent years.

**2. Recent Price Movement:**

* **Closing Price:** $9.44
* **5-day Moving Average:** $9.13
* **20-day Moving Average:** $9.16
* **60-day Moving Average:** $8.36

TDOC's price is currently above its 5-day and 20-day moving averages, indicating potential short-term bullish momentum.  However, it is still below its 60-day moving average, suggesting a longer-term downtrend.

**3. Technical Indicators:**

* **RSI:** 49.08 - This indicates a neutral market sentiment, neither overbought nor oversold.
* **PPO:** -0.13 -  A negative PPO suggests the stock is in a downtrend, albeit a relatively weak one.
* **Delta_Previous_Relative_Divergence:** -0.67 (-) - This indicates a short-term decline in the stock's relative divergence from its historical average.
* **Expected Return:** 0.0% -  Based on the current data, the expected return for a long-term investment in TDOC is projected to be 0% relative to the S&P 500.

**4. Recent Earnings & Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-10-31 | -0.19 | 0.64 B$ |
| 2024-08-01 | -4.92 | 0.64 B$ |
| 2024-04-26 | -0.49 | 0.65 B$ |
| 2023-10-27 | -0.35 | 0.66 B$ |
| 2024-10-31 | -0.35 | 0.66 B$ |

Teladoc's recent earnings have been consistently below analyst expectations,  signaling potential challenges for the company's profitability. The company's most recent earnings call is missing, so a more in-depth analysis is not available.

**5. Financial Information:**

**1) Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---|---|---|
| 2024-09-30  | $0.64B | 71.94% |
| 2024-06-30  | $0.64B | 70.73% |
| 2024-03-31  | $0.65B | 69.89% |
| 2023-12-31  | $0.66B | 70.72% |
| 2023-09-30  | $0.66B | 71.83% |

Teladoc's revenue has been relatively stable in recent quarters.  While its profit margin remains strong, indicating the potential for profitability, the company's consistent profitability is concerning due to its significant losses in recent years. 

**2) Capital and Profitability:**

| Quarter | Equity | ROE |
|---|---|---|
| 2024-09-30 | $1.51B | -2.21% |
| 2024-06-30 | $1.50B | -55.77% |
| 2024-03-31 | $2.29B | -3.58% |
| 2023-12-31 | $2.33B | -1.24% |
| 2023-09-30 | $2.29B | -2.49% |

Teladoc's ROE has been consistently negative for the past few quarters, highlighting the company's struggle to generate returns on its equity. This could be a concern for investors, indicating potential challenges in profitability.

**6. News and Recent Issues:**

**Recent Market Outlook:**

* **Recent Market Outlook:**  Despite some recent positive earnings from other telehealth companies, TDOC has struggled to gain traction. 
* **Analyst Opinions:** Analyst opinions vary on TDOC. Some analysts see potential for future growth, particularly as the telehealth market matures and consumer adoption increases. However, others remain concerned about the company's profitability and market share.
* **Performance Highlights:**  TDOC's performance has been volatile and inconsistent, leading to investor uncertainty. The company is currently in the midst of restructuring, which could impact future performance.

**7. Comprehensive Analysis:**

Teladoc Health Inc (TDOC) is a telehealth company that provides virtual healthcare services. The company has experienced significant volatility in its stock price, with a history of both strong alpha and underperformance.  Recent earnings have been below expectations, raising concerns about the company's ability to achieve consistent profitability.  While the company is restructuring, the overall outlook remains uncertain. 

Investors should carefully consider the risks and opportunities associated with TDOC before making any investment decisions. 

**8. Summary:**

* TDOC has underperformed the S&P 500 significantly in recent years, with a considerable negative divergence.
* The stock has shown some short-term bullish momentum, but the long-term trend remains negative.
* Technical indicators suggest a neutral market sentiment and a weak downtrend.
* Recent earnings have been below expectations, raising concerns about the company's profitability.
* Financial information indicates stable revenue but consistent negative ROE, reflecting profitability challenges.
* The company is restructuring, but the overall market outlook remains uncertain.

**9. Investment Recommendation:**

Given the current market conditions, it is recommended that investors exercise caution when considering TDOC. The company has faced significant challenges, and its future performance remains uncertain.  If investing in TDOC, a long-term approach with a focus on gradual accumulation over time may be more suitable than attempting to time the market.  It is also advisable to consult with a financial advisor to assess your individual risk tolerance and investment goals. 
